Treatment of Candida auris During Extracorporeal Life Support: A Case Report

Authors

Paul Dobry
Stephanie B. Edwin
Tsz Hin Ng
Karey Dutcheshen
Amir Kaki, Corewell Health
Theodore L. Schreiber, Corewell Health

Document Type

Article

Publication Date

3-1-2024

Publication Title

International Journal of Artificial Organs

Abstract

With rates of ECMO utilization on the rise, prevention of nosocomial infections is of paramount importance. Candida auris, an emerging highly pathogenic multidrug resistant fungus, is of particular concern as it is associated with persistent colonization of environmental surfaces, inability to be recognized by many diagnostic platforms, inconsistent laboratory susceptibility results, and high mortality rates. We describe a case of C. auris in a VV-ECMO patient successfully managed with a combination of anidulafungin, amphotericin B, and flucytosine.

Volume

47

Issue

3

First Page

223

Last Page

226

Recommended Citation

Dobry P, Edwin SB, Ng TH, Dutcheshen K, Kaki A, Schreiber TL. Treatment of Candida auris during extracorporeal life support: a case report. Int J Artif Organs. 2024 Mar;47(3):223-226. doi: 10.1177/03913988231226357. PMID: 38281934.

DOI

10.1177/03913988231226357

ISSN

1724-6040

PubMed ID

38281934